Davida Kamara

1.5k total citations
8 papers, 328 citations indexed

About

Davida Kamara is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Davida Kamara has authored 8 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Davida Kamara's work include Cancer therapeutics and mechanisms (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and RNA modifications and cancer (1 paper). Davida Kamara is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and RNA modifications and cancer (1 paper). Davida Kamara collaborates with scholars based in United States and China. Davida Kamara's co-authors include E. Anders Kolb, Valerie B. Sampson, Richard Görlick, Myriam Gorospe, Subramanya Srikantan, Stefanie Galbán, Kevin G. Becker, Yuki Kuwano, Kotb Abdelmohsen and Xiaoling Yang and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Frontiers in Oncology.

In The Last Decade

Davida Kamara

8 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davida Kamara United States 6 229 85 83 63 23 8 328
Rachel Ruoff United States 12 228 1.0× 111 1.3× 61 0.7× 71 1.1× 47 2.0× 15 336
Ioanna Mavrommati United Kingdom 8 307 1.3× 47 0.6× 61 0.7× 131 2.1× 19 0.8× 9 436
Runyi Ye China 12 192 0.8× 45 0.5× 142 1.7× 66 1.0× 14 0.6× 15 306
Adele Servadio Italy 11 157 0.7× 88 1.0× 78 0.9× 101 1.6× 34 1.5× 18 312
Wuzhong Jiang China 9 213 0.9× 63 0.7× 104 1.3× 104 1.7× 16 0.7× 17 337
Dilys T.H. Leung Australia 9 177 0.8× 53 0.6× 110 1.3× 77 1.2× 38 1.7× 10 340
Tadahiko Nakagawa Japan 10 178 0.8× 64 0.8× 65 0.8× 98 1.6× 29 1.3× 25 331
Sunao Tanaka Japan 10 184 0.8× 29 0.3× 107 1.3× 98 1.6× 26 1.1× 26 328
Helena Nord Sweden 13 212 0.9× 47 0.6× 102 1.2× 58 0.9× 80 3.5× 19 364
Katsuaki Masuda Japan 10 321 1.4× 109 1.3× 53 0.6× 69 1.1× 26 1.1× 13 417

Countries citing papers authored by Davida Kamara

Since Specialization
Citations

This map shows the geographic impact of Davida Kamara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davida Kamara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davida Kamara more than expected).

Fields of papers citing papers by Davida Kamara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davida Kamara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davida Kamara. The network helps show where Davida Kamara may publish in the future.

Co-authorship network of co-authors of Davida Kamara

This figure shows the co-authorship network connecting the top 25 collaborators of Davida Kamara. A scholar is included among the top collaborators of Davida Kamara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davida Kamara. Davida Kamara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sampson, Valerie B., et al.. (2015). Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways. PLoS ONE. 10(11). e0142704–e0142704. 36 indexed citations
2.
Geng, Tuoyu, Lili Xia, Sarah Russo, Davida Kamara, & L. Ashley Cowart. (2015). Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice. Nutrition Research. 35(9). 812–822. 15 indexed citations
3.
Sampson, Valerie B., Richard Görlick, Davida Kamara, & E. Anders Kolb. (2013). A Review of Targeted Therapies Evaluated by the Pediatric Preclinical Testing Program for Osteosarcoma. Frontiers in Oncology. 3. 132–132. 43 indexed citations
4.
Sampson, Valerie B., Davida Kamara, & E. Anders Kolb. (2013). Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery. Expert Opinion on Drug Discovery. 8(10). 1181–1189. 24 indexed citations
5.
Stabley, Deborah L., Davida Kamara, Jennifer Holbrook, et al.. (2010). Digital Gene Expression of miRNA in Osteosarcoma Xenografts: Finding Biological Relevance in miRNA High Throughput Sequencing Data. Journal of Biomolecular Techniques JBT. 21. 2 indexed citations
6.
Kolb, E. Anders, Davida Kamara, Wendong Zhang, et al.. (2010). R1507, a fully human monoclonal antibody targeting IGF‐1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts. Pediatric Blood & Cancer. 55(1). 67–75. 68 indexed citations
7.
Abdelmohsen, Kotb, Subramanya Srikantan, Xiaoling Yang, et al.. (2009). Ubiquitin‐mediated proteolysis of HuR by heat shock. The EMBO Journal. 28(9). 1271–1282. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026